Transcriptional control of pluripotent stem cell fate by the Nucleosome Remodelling and Deacetylation (NuRD) complex

Add to your list(s) Download to your calendar using vCal

• Dr Brian Hendrich; Cambridge Stem Cell Institute, University of Cambridge
• Wednesday 28 February 2018, 13:00-14:00
• Babraham - The Cambridge Building; Kings Hedges Room.

If you have a question about this talk, please contact Bobbie Claxton.

If you would like to attend this seminar, please contact us to arrange site access

Chromatin remodelling complexes play essential roles in metazoan development through widespread control of gene expression. The genetic requirements for many of the components of such complexes have been described, and their biochemical activities characterised in vitro, yet the precise molecular mechanisms by which chromatin remodellers impact transcriptional regulation in vivo remain ill-defined. In my lab we have been studying the Nucleosome Remodelling and Deacetylation (NuRD) complex in mouse ES cells. Functionally, NuRD is required for pluripotent cells to properly undergo lineage commitment both in vitro and in vivo, and mouse embryos lacking key NuRD components die in peri-implantation stages. Despite these profound developmental defects, NuRD deficiency in ES cells results in only moderate gene expression changes, with the majority of genes changing by less than two-fold. These small transcriptional changes nevertheless result in a profound phenotype of developmental failure. I will present or latest results in defining molecularly how the enzymatic activities of NuRD fine-tune transcription in mouse ES cells, and how biochemical dissection of NuRD can be used to define NuRD function during lineage commitment.

This talk is part of the Babraham Seminar series.

This talk is included in these lists:

• Babraham - The Cambridge Building; Kings Hedges Room
• Babraham Seminar
• Graduate-Seminars
• se393's list

Note that ex-directory lists are not shown.